Related Experiment Video
Updated: May 27, 2025
08:56
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.6K
Anaesthesia management in a patient with a cardiac contractility modulation device
Ana Álvarez Bartolomé1, Álvaro Mingote2, María Casado Salcedo1
1Servicio de Anestesiología, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.
Revista Espanola De Anestesiologia Y Reanimacion
|February 16, 2025
Summary
Cardiac contractility modulation (CCM) therapy improves heart failure symptoms. Anesthesia management for patients with CCM devices is crucial, as guidelines are lacking, and encounters will increase.
Area of Science:
- Cardiology
- Anesthesiology
- Medical Devices
Background:
- Cardiac contractility modulation (CCM) is an electrical therapy for moderate-to-severe heart failure.
- CCM offers modest benefits in exercise tolerance and quality of life for heart failure patients.
Observation:
- Current guidelines for implantable cardiac devices do not address CCM management.
- Limited literature exists on anesthesia considerations for patients with CCM devices.
Findings:
- This case report details the anesthesia management of a patient with a CCM device.
- The report highlights practical considerations for perioperative care.
Implications:
- Anesthesiologists will likely encounter more patients with CCM devices in clinical practice.
- Developing specific anesthesia guidelines for CCM patients is warranted.
- This case provides a foundation for future research and clinical protocols.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
385
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
385
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
703
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
703
01:26Heart Failure Drugs: Inotropic Agents
500
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
500
01:21Skeletal Muscle Relaxants: Adverse Effects
330
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
330
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K